Osmotic demyelination syndrome: plasmapheresis versus intravenous immunoglobulin?

Intern Emerg Med. 2017 Feb;12(1):123-126. doi: 10.1007/s11739-016-1452-4. Epub 2016 Apr 18.

Authors

Kunakorn Atchaneeyasakul¹, Anita Tipirneni¹, Salomon Gloria¹, Andrew C Berry², Kush Shah³, Dileep R Yavagal¹

Affiliations

¹ Department of Neurology, Jackson Memorial Hospital, University of Miami School of Medicine, Miami, FL, USA.
² Department of Medicine, University of South Alabama, 2451 Fillingim St., Mobile, AL, 36617-2238, USA. aberry5555@gmail.com.
³ Department of Radiology, Jackson Memorial Hospital, University of Miami School of Medicine, Miami, FL, USA.

PMID: 27091143
DOI: 10.1007/s11739-016-1452-4

No abstract available

Publication types

Case Reports

MeSH terms

Demyelinating Diseases / complications
Demyelinating Diseases / diagnostic imaging
Demyelinating Diseases / etiology*
Humans
Immunoglobulins, Intravenous / pharmacology*
Immunoglobulins, Intravenous / therapeutic use
Liver Transplantation
Male
Middle Aged
Non-alcoholic Fatty Liver Disease / complications*
Plasmapheresis / methods
Plasmapheresis / standards*
Pons / abnormalities

Substances

Immunoglobulins, Intravenous